Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Arbutus Biopharma Corp (NASDAQ: ABUS) closed at $3.06 down -1.61% from its previous closing price of $3.11. In other words, the price has decreased by -$1.61 from its previous closing price. On the day, 0.8 million shares were traded.
Ratios:
For a deeper understanding of Arbutus Biopharma Corp’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.02 and its Current Ratio is at 7.02. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.06.
On February 25, 2021, Jefferies started tracking the stock assigning a Hold rating and target price of $5.
On December 17, 2020, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.H.C. Wainwright initiated its Buy rating on December 17, 2020, with a $10 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 07 ’25 when Sofia Michael J. bought 167,162 shares for $3.29 per share.
HASTINGS DAVID C sold 22,183 shares of ABUS for $72,827 on Feb 04 ’25. The Chief Financial Officer now owns 159,724 shares after completing the transaction at $3.28 per share. On Feb 04 ’25, another insider, Sims Karen, who serves as the Chief Medical Officer of the company, sold 19,348 shares for $3.28 each. As a result, the insider received 63,519 and left with 106,194 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 86.03 while its Price-to-Book (P/B) ratio in mrq is 5.42.
Stock Price History:
Over the past 52 weeks, ABUS has reached a high of $4.72, while it has fallen to a 52-week low of $2.30. The 50-Day Moving Average of the stock is -8.05%, while the 200-Day Moving Average is calculated to be -14.76%.
Shares Statistics:
A total of 189.44M shares are outstanding, with a floating share count of 147.08M. Insiders hold about 22.38% of the company’s shares, while institutions hold 54.97% stake in the company.
